Position in ZVRA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$2,454,305
+$821,143 QoQ
Shares Held
171,151
-2.3% QoQ
Ownership
0.288%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#45
of 158 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kovack Advisors, Inc. holds $5,014,818 across 13 Biotechnology names. ZVRA ranks #1 (48.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZVRA |
Zevra Therapeutics, Inc.
This page
|
171,151 | $2,454,305 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,315 | $653,199 | |
| 3 | MRNA |
Moderna, Inc.
|
3,995 | $279,769 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,675 | $273,714 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
4,936 | $269,209 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
392 | $244,427 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
921 | $221,933 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
20,808 | $182,174 |
All Filings in ZVRA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,454,305 | 171,151 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,633,162 | 175,232 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,570,965 | 175,331 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,666,941 | 175,283 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,293,202 | 146,788 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,099,135 | 146,747 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,218,957 | 146,158 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,032,685 | 148,802 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $732,706 | 149,532 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $822,706 | 141,846 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $926,176 | 141,401 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $598,205 | 124,109 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $618,721 | 121,318 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $675,521 | 122,822 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $490,872 | 106,944 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $680,496 | 109,054 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $383,961 | 86,090 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $494,559 | 98,322 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $769,066 | 88,297 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $636,865 | 68,260 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $774,058 | 60,379 | Shares | Sole | 2021-07-29 | |
| No filing history on record for this holder in this stock. | ||||||